Alternatives to Infiniplex

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Comprehensive whole-genome monitoring for cancer recurrence and progression.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Personalized nutrition and metabolic health platform using gut microbiome and AI.

Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

Scent-based multi-cancer early detection screening test using AI and bio-detectors.

Develops AI-powered decision support tools for personalized medical data interpretation and prediction.

Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.

A medical platform connecting patients and physicians with genetic expertise.

Transforming healthcare by turning scientific fiction into scientific facts.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Develops a computational model of the human body for drug discovery and development.